Plasma monoamine metabolites and aggression: two studies of normal and oppositional defiant disorder children

By van Goozen S.H.M.   Matthys W.   Cohen-Kettenis P.T.   Westenberg H.   van Engeland H.  

European Neuropsychopharmacology, Vol. 9, Iss. 1, 1999-01 ,pp. : 141-147

Elsevier

Access to resources Recommend Favorite

Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data

By Biederman Joseph   Spencer Thomas   Newcorn Jeffrey   Gao Haitao   Milton Denái   Feldman Peter   Witte Michael  

Psychopharmacology, Vol. 190, Iss. 1, 2007-01 ,pp. : 31-41

Springer Publishing Company

Access to resources Recommend Favorite

Brain Structural Effects of Psychopharmacological Treatment in Bipolar Disorder

By  

Current Neuropharmacology, Vol. 13, Iss. 4, 2015-01 ,pp. : 445-457

Bentham Science Publishers

Access to resources Recommend Favorite

Identifying Genetic Variants in Adolescents With Oppositional Defiant Disorders and/or Conduct Disorders: A Brief Report

By  

Journal Of Child And Adolescent Psychiatric Nursin G (Electronic), Vol. 29, Iss. 3, 2016-08 ,pp. : 154-157

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of Recurrent Depression: A Sequential Psychotherapeutic and Psychopharmacological Approach

By Fava G.A.   Ruini C.   Sonino N.  

CNS Drugs, Vol. 17, Iss. 15, 2003-01 ,pp. : 1109-1117

Adis International

Access to resources Recommend Favorite